U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07940803) titled 'A Research Study of a New Medicine NNC0662-3168 for Weight Management and Type 2 Diabetes' on Nov. 11.

Brief Summary: The purpose of this study is to learn more about NNC0662-3168 as a potential treatment for people living with overweight or obesity and/or type 2 diabetes(T2D). The study will investigate its safety, tolerability and its effects in the body. The study will be conducted in four parts. Part A: Single Ascending Dose, Part B: Multiple Ascending Dose: Part C: Dose-finding in Weight Management. Part D: T2D proof-of-concept.

Study Start Date: Nov. 13

Study Type: INTERVENTIONAL

Condition: Overweight Obesity Type 2 Diabet...